| Literature DB >> 35548665 |
Yanyan Yin1, Li Jiang2, Lixin Xue3.
Abstract
Purpose: To determine which frailty method can better improve the predictive ability of the Surgical Apgar Score combined with American Society of Anesthesiologists physical status classification (SASA). Patients andEntities:
Keywords: frailty assessment; postoperative complication; risk assessment tool
Year: 2022 PMID: 35548665 PMCID: PMC9084513 DOI: 10.2147/TCRM.S357285
Source DB: PubMed Journal: Ther Clin Risk Manag ISSN: 1176-6336 Impact factor: 2.755
Characteristics of the Patients at Baseline
| Characteristics | Total (n=194) | FRAIL≥3 (n=85) | FI>0.4 (n=63) | CFS≥5 (n=71) |
|---|---|---|---|---|
| Age (years), mean (SD) | 77.0 (7.7) | 81.9 (5.2)* | 82.1 (5.7)* | 81.7 (5.9)* |
| Male, n (%) | 90 (46.4) | 33 (38.8) | 21 (33.3)* | 26 (36.6)* |
| BMI (kg/m2), mean (SD) | 23.8 (2.2) | 23.9 (2.2) | 23.8 (2.3) | 23.7 (2.2) |
| * | * | * | ||
| Illiterate | 6 (3.1) | 4 (4.7) | 3 (3.5) | 3 (4.2) |
| Elementary school | 45 (23.2) | 27 (31.8) | 20 (23.5) | 24 (33.8) |
| Junior/senior high school | 125 (64.4) | 51 (60) | 39 (45.9) | 43 (60.6) |
| Undergraduate | 18 (9.3) | 3 (3.5) | 1 (1.2) | 1 (1.4) |
| Gastrointestinal | 75(38.7) | 30(35.3) | 27(42.9) | 27(38.0) |
| Cholecystic | 53(27.3) | 29(34.1) | 20(31.7) | 25(35.2) |
| Epityphlon | 31(16.0) | 10(11.8) | 5(7.9) | 6(8.5) |
| Urinary system | 18(9.3) | 8(9.4) | 5(7.9) | 6(8.5) |
| Gynecology | 17(8.8) | 8(9.4) | 6(9.5) | 7(9.9) |
| Presence of malignancy, n (%) | * | * | * | |
| None | 107 (55.2) | 48 (56.5) | 31 (49.2) | 35 (49.3) |
| Primary only | 55 (28.4) | 17 (20.0) | 15 (23.8) | 16 (22.5) |
| Metastases | 32 (16.5) | 20 (23.5) | 17 (27.0) | 20 (28.2) |
| Current smoker, n (%) | 18 (9.3) | 5 (5.9) | 2 (3.2)* | 2 (2.8)* |
| Current drinker, n (%) | 12 (6.2) | 5 (5.9) | 4 (6.3) | 4 (5.6) |
| CCI, mean (SD) | 1.7 (1.2) | 1.7 (1.3) | 2.0 (1.5) | 1.9 (1.4) |
| ADL, median (IQR) | 85 (20) | 75(10)* | 70(15)* | 70(15)* |
| ASA score | * | * | * | |
| 2 | 35 (18.0) | 11 (12.9) | 8 (12.7) | 7 (9.9) |
| 3 | 154 (79.4) | 69 (81.2) | 51 (81.0) | 60 (84.5) |
| 4 | 5 (2.6) | 5 (5.9) | 4 (6.3) | 4 (5.6) |
| Surgery duration (hours), median (IQR) | 1.8(1.1) | 1.8(0.8) | 1.8(0.9) | 1.9(1.0) |
| Total blood loss (mL), median (IQR) | 200 (300) | 200 (300) | 200 (300)* | 200 (300)* |
| Mean arterial pressure, mean (SD) | 73.0 (10.0) | 69.5 (10.5)* | 68.2 (9.7)* | 68.7 (10.6)* |
| Lowest heart rate, mean (SD) | 68.3 (9.8) | 71.7 (10.9)* | 72.5 (11.4)* | 72.1 (11.6)* |
| SASA, median (IQR) | 14(3) | 13(2)* | 13(4)* | 13(3)* |
Note: *Significant difference can be seen between frail and non-frail group.
Abbreviations: BMI, body mass index; CCI, Charlson comorbidity index; ADL, activities of daily living; ASA, American Society of Anesthesiologists; FI, frailty index; CFS, clinical frailty scale.
Association Between Frailty Category and In-Hospital Postoperative Complications
| Complications/Classification | By FRAIL | By FI | By CFS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-Frail | Frail | P-value | Non-Frail | Frail | P-value | Non-Frail | Frail | P-value | |
| Complications, n | 19 | 39 | <0.001 | 23 | 35 | <0.001 | 20 | 38 | <0.001 |
| Clavien-Dindo classification, n | 0.001 | 0.002 | <0.001 | ||||||
| Grade 2 | 10 | 3 | 10 | 3 | 12 | 1 | |||
| Grade 3 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Grade 4 | 5 | 21 | 10 | 16 | 5 | 21 | |||
| Grade 5 | 4 | 15 | 3 | 16 | 3 | 16 | |||
Univariate Logistic Regression of Postoperative Complications in Hospital
| Characteristic | OR (95% CI) | P-value |
|---|---|---|
| Age | 1.03 (0.99, 1.07) | 0.164 |
| Gender | ||
| Male | 1.00 | N/A |
| Female | 1.64 (0.87, 3.07) | 0.124 |
| Education | ||
| Illiterate | 1 | N/A |
| Elementary | 0.28 (0.05, 1.68) | 0.162 |
| Junior/senior high school | 0.18 (0.03, 1.03) | 0.053 |
| Undergraduate | 0.19 (0.03, 1.40) | 0.104 |
| Presence of malignancy | ||
| None | 1.00 | N/A |
| Primary only | 2.13 (0.96, 4.73) | 0.062 |
| Metastases | 30.71 (10.30, 91.55) | <0.001 |
| Current smoking status | 1.12 (0.38, 3.30) | 0.837 |
| Current drinking status | 0.84 (0.24, 2.92) | 0.789 |
| BMI | 1.13 (0.98, 1.31) | 0.091 |
| CCI | 2.78 (1.66, 4.63) | <0.001 |
| ADL | 0.96 (0.94, 0.98) | <0.001 |
| ASA | 2.94 (1.25, 6.94) | 0.014 |
| Type of surgery | ||
| Gastrointestinal | 1.00 | N/A |
| Cholecystic | 0.30 (0.13, 0.68) | 0.004 |
| Epityphlon | 0.14 (0.04, 0.49) | 0.002 |
| Urinary system | 0.64 (0.22, 1.88) | 0.412 |
| Gynecology | 0.69 (0.23, 2.07) | 0.513 |
| Surgery variables | ||
| Surgery duration | 1.97 (1.37, 2.83) | <0.001 |
| Total blood loss | 1.01 (1.01, 1.01) | <0.001 |
| SASA | 0.33 (0.24, 0.45) | <0.001 |
| Frailty status (FRAIL) | ||
| Non-frail | 1.00 | N/A |
| Frail | 4.02 (2.09, 7.72) | <0.001 |
| Frailty status (FI) | ||
| Non-frail | 1.00 | N/A |
| Frail | 5.87 (3.00, 11.48) | <0.001 |
| Frailty status (CFS) | ||
| Non-frail | 1.00 | N/A |
| Frail | 5.93 (3.04, 11.57) | <0.001 |
Multiple Logistic Regression Analysis of In-Hospital Postoperative Complications
| Non-Adjusted OR (95% CI) | Model I OR (95% CI) | Model II OR (95% CI) | Model III OR (95% CI) | |
|---|---|---|---|---|
| Frailtya | 4.02 (2.09, 7.72), <0.001 | 5.37 (2.28, 12.66), <0.001 | 4.77 (1.35, 16.90), 0.016 | 5.11 (1.41, 18.44), 0.013 |
| Frailtyb | 5.87 (3.00, 11.48),<0.001 | 7.53 (3.30, 17.22), <0.001 | 3.88 (1.14,13.22), 0.030 | 4.25 (1.21,14.90), 0.024 |
| Frailtyc | 5.93 (3.04, 11.57),<0.001 | 7.80 (3.42, 17.80), <0.001 | 5.02 (1.52,16.56), 0.008 | 5.10 (1.52, 17.17), 0.008 |
| SASA | 0.33 (0.24, 0.45), <0.001 | 0.31 (0.23, 0.44), <0.001 | 0.33 (0.21, 0.53), <0.001 | 0.32 (0.20, 0.51), <0.001 |
Notes: aFRAIL; bFI; cCFS. Model I:+age and gender; Model II:+ presence of malignancy, BMI, CCI, ADL, ASA, type of surgery, surgery duration, total blood loss; Model III:+all covariates.
Figure 1Receiver operating characteristic (ROC) curves showing the predictive ability of three different frailty method and SASA.
Figure 2Receiver operating characteristic (ROC) curves showing the predictive ability of three different frailty method+SASA and SASA.
Performance of Risk Assessment Tool and Frailty Assessment Methods in Predicting Postoperative Complications
| Cox&Snell R2 | Nagelkerke R2 | Hosmer-Lemeshow | AUC (95% CI) | ΔAUC (P-value)★* | |
|---|---|---|---|---|---|
| SASA | 0.194 | 0.276 | 10.531 (0.104) | 0.768 (0.702, 0.826) | |
| Frailtya | 0.082 | 0.117 | 4.176 (0.243) | 0.684 (0.614, 0.749) | ★0.1034 |
| SASA+ Frailtya | 0.219 | 0.310 | 17.689 (0.024) | 0.787 (0.722, 0.842) | *0.0186 (0.2802) |
| Frailtyb | 0.119 | 0.169 | 22.276 (0.004) | 0.728 (0.660, 0.789) | ★0.4586 |
| SASA+ Frailtyb | 0.236 | 0.335 | 16.976 (0.030) | 0.798 (0.734, 0.852) | *0.0296 (0.1455) |
| Frailtyc | 0.168 | 0.239 | 3.805 (0.283) | 0.753 (0.686, 0.812) | ★0.7411 |
| SASA+ Frailtyc | 0.255 | 0.362 | 8.637 (0.280) | 0.815 (0.753, 0.867) | *0.0471 (0.0478) |
Notes: aFRAIL; bFrailty index; cClinical frailty score. ★Difference between SASA and any frailty evaluation method. *Difference between SASA and SASA +any frailty evaluation method.